Bayer HealthCare has signed a master agreement for the conduct of clinical trials with the University of Texas MD Anderson Cancer Center aimed at supporting collaborative clinical programs in oncology.   Bayer’s oncology franchise is exploring specific treatment approaches for various tumors, including common types of cancer such as prostate, colorectal, and breast cancer, and more rare forms, like kidney, liver and thyroid cancer. MD Anderson Cancer Center is among the world’s most respec...